The London Borough of Sutton has confirmed the selection of Socius and Aviva as partners to advance the development of the world’s leading district for cancer research and treatment at the London Cancer Hub (LCH) in Sutton, London.
The landmark investment includes the long lease sale for development of a five-hectare site adjacent to the renowned Royal Marsden hospital and globally recognised Institute for Cancer Research. The partnership will deliver one million square feet of research, treatment and innovation spaces alongside residential accommodation and amenities for local people and visitors. It will be one of London’s most significant regeneration projects and once completed will make Sutton, and the capital, home to the world’s largest cancer life science district.
The site, known as the London Cancer Hub, is already ranked number one in Europe for cancer research and treatment. In addition to the Institute for Cancer Research and Royal Marsden NHS Foundation Trust, it is home to the cancer care support provider Maggie’s, the Harris Academy and the Council’s own Innovation Gateway, that provides start-ups working in areas related to cancer with high-quality laboratory, office and collaboration space.
The new development will deliver major social and economic benefits for the UK, contributing circa £1.2bn to the UK economy and £12 million increase in business rates. 13,000 jobs in health, science, education and construction will be created as part of the project, as well as space for start-up, growing and established businesses.
Socius & Aviva have commenced community and stakeholder engagement with a view to submitting a planning application in late 2024.